Pages that link to "Infliximab"
Appearance
Showing 500 items.
- Rheumatoid arthritis (links | edit)
- Tuberculosis (links | edit)
- Thalidomide (links | edit)
- Crohn's disease (links | edit)
- Ulcerative colitis (links | edit)
- Psoriasis (links | edit)
- Ciclosporin (links | edit)
- Tacrolimus (links | edit)
- Rheumatology (links | edit)
- Tumor necrosis factor (links | edit)
- Immunosuppressive drug (links | edit)
- Ertapenem (links | edit)
- Methotrexate (links | edit)
- Sarcoidosis (links | edit)
- Alcoholic liver disease (links | edit)
- Monoclonal antibody (links | edit)
- Infliximab (transclusion) (links | edit)
- Loratadine (links | edit)
- Merck Index (links | edit)
- Schering-Plough (links | edit)
- Ankylosing spondylitis (links | edit)
- Disease-modifying antirheumatic drug (links | edit)
- Azathioprine (links | edit)
- Enteritis (links | edit)
- Sirolimus (links | edit)
- Everolimus (links | edit)
- Mycophenolic acid (links | edit)
- Basiliximab (links | edit)
- Daclizumab (links | edit)
- Anti-thymocyte globulin (links | edit)
- Anti-lymphocyte globulin (links | edit)
- Amyloidosis (links | edit)
- Hidradenitis suppurativa (links | edit)
- Psoriatic arthritis (links | edit)
- 1986 in science (links | edit)
- International nonproprietary name (links | edit)
- Simvastatin (links | edit)
- Rofecoxib (links | edit)
- Etanercept (links | edit)
- Desloratadine (links | edit)
- ATC code L (links | edit)
- ATC code L04 (links | edit)
- Ezetimibe (links | edit)
- Antiserum (links | edit)
- Juvenile dermatomyositis (links | edit)
- Rizatriptan (links | edit)
- Rectovaginal fistula (links | edit)
- Remicade (redirect page) (links | edit)
- Columbia University (links | edit)
- Listerine (links | edit)
- Band-Aid (links | edit)
- Tylenol (brand) (links | edit)
- Johnson & Johnson (links | edit)
- Benadryl (links | edit)
- Alza (links | edit)
- Robert Wood Johnson II (links | edit)
- Acuvue (links | edit)
- Mylanta (links | edit)
- James E. Burke (links | edit)
- Ethicon (links | edit)
- Neutrogena (links | edit)
- DePuy Synthes (links | edit)
- Visine (links | edit)
- Tibotec (links | edit)
- Janssen Pharmaceuticals (links | edit)
- Penaten (links | edit)
- Fine chemical (links | edit)
- Robert Wood Johnson I (links | edit)
- Robert Wood Johnson III (links | edit)
- Ortho-McNeil Pharmaceutical (links | edit)
- Prolene (links | edit)
- Hubert Schoemaker (links | edit)
- Benecol (links | edit)
- Bengay (links | edit)
- Aveeno (links | edit)
- Abiomed (links | edit)
- Clean & Clear (links | edit)
- Janssen Vaccines (links | edit)
- Cilag (links | edit)
- McNeil Consumer Healthcare (links | edit)
- LifeScan (links | edit)
- Johnson & Johnson Pharmaceutical Research and Development (links | edit)
- Fred Hassan (links | edit)
- William C. Weldon (links | edit)
- Mentor (company) (links | edit)
- NYU Langone Health (links | edit)
- James Wood Johnson (links | edit)
- Vilcek Institute of Graduate Biomedical Sciences (links | edit)
- Sinutab (links | edit)
- Richard B. Sellars (links | edit)
- Philip B. Hofmann (links | edit)
- Neil Melanson (links | edit)
- Merck & Co. (links | edit)
- Actelion (links | edit)
- Alex Gorsky (links | edit)
- Ralph S. Larsen (links | edit)
- Johnson's Baby (links | edit)
- Reach (brand) (links | edit)
- Janssen COVID-19 vaccine (links | edit)
- List of Johnson & Johnson products and services (links | edit)
- Naproxen/pseudoephedrine (links | edit)
- Joaquin Duato (links | edit)
- Niraparib/abiraterone acetate (links | edit)
- Kenvue (links | edit)
- Talk:Small molecule (links | edit)
- Talk:Natalizumab/Archive 2 (links | edit)
- Talk:Remicade (links | edit)
- User:Chefmikesf/sandbox/Joaquin Duato (links | edit)
- User:Wissenswart/corpus analysis (links | edit)
- Wikipedia:WikiProject Pharmacology/Top 200 US Prescriptions 2011 (links | edit)
- Wikipedia:In the news/Candidates/March 2015 (links | edit)
- Wikipedia:Articles for deletion/Log/2015 May 20 (links | edit)
- Wikipedia:Articles for deletion/Panadol (links | edit)
- Template:Johnson & Johnson (links | edit)
- Template talk:Johnson & Johnson (links | edit)
- Portal:Current events/August 2004 (links | edit)
- Portal:Current events/March 2015 (links | edit)
- Portal:Current events/2015 March 6 (links | edit)
- Portal:Current events/2004 August 24 (links | edit)
- Amgen (links | edit)
- Medicinal chemistry (links | edit)
- Toxic epidermal necrolysis (links | edit)
- Alendronic acid (links | edit)
- Freeze drying (links | edit)
- Ezetimibe/simvastatin (links | edit)
- Kawasaki disease (links | edit)
- Uveitis (links | edit)
- William B. Harrison Jr. (links | edit)
- Index of oncology articles (links | edit)
- Merck Manual of Diagnosis and Therapy (links | edit)
- Finasteride (links | edit)
- Omalizumab (links | edit)
- Montelukast (links | edit)
- Fingolimod (links | edit)
- New York University Grossman School of Medicine (links | edit)
- Adalimumab (links | edit)
- Anakinra (links | edit)
- Neurosarcoidosis (links | edit)
- Richard Clark (business executive) (links | edit)
- Lenalidomide (links | edit)
- List of drugs: Im–In (links | edit)
- List of drugs: Re (links | edit)
- Natalizumab (links | edit)
- Urofollitropin (links | edit)
- Losartan (links | edit)
- Fungemia (links | edit)
- Biopharmaceutical (links | edit)
- Downstream processing (links | edit)
- Cladribine (links | edit)
- Alemtuzumab (links | edit)
- Pyoderma gangrenosum (links | edit)
- Janssen Pharmaceuticals (links | edit)
- Rocuronium bromide (links | edit)
- Pachydermoperiostosis (links | edit)
- Immune reconstitution inflammatory syndrome (links | edit)
- Experimental autoimmune encephalomyelitis (links | edit)
- Indinavir (links | edit)
- Collagenous colitis (links | edit)
- Leflunomide (links | edit)
- Famciclovir (links | edit)
- Merck Veterinary Manual (links | edit)
- Theralizumab (links | edit)
- Humanized antibody (links | edit)
- Descending colon (links | edit)
- Muromonab-CD3 (links | edit)
- Tibolone (links | edit)
- Dercum's disease (links | edit)
- Efalizumab (links | edit)
- Sitagliptin (links | edit)
- Mometasone (links | edit)
- Graves' ophthalmopathy (links | edit)
- Alefacept (links | edit)
- TNF inhibitor (links | edit)
- Management of Crohn's disease (links | edit)
- TNF receptor superfamily (links | edit)
- Gusperimus (links | edit)
- Management of ulcerative colitis (links | edit)
- TNF receptor associated periodic syndrome (links | edit)
- Certolizumab pegol (links | edit)
- Raltegravir (links | edit)
- Your Health Now (links | edit)
- Biological therapy for inflammatory bowel disease (links | edit)
- Jan Vilček (links | edit)
- Eculizumab (links | edit)
- Monoclonal antibody therapy (links | edit)
- Vorinostat (links | edit)
- Lymphotoxin (links | edit)
- Orofacial granulomatosis (links | edit)
- Drug-induced lupus erythematosus (links | edit)
- Mevalonate kinase deficiency (links | edit)
- Belatacept (links | edit)
- Biological response modifier (links | edit)
- Apolizumab (links | edit)
- Inflammatory demyelinating diseases of the central nervous system (links | edit)
- List of therapeutic monoclonal antibodies (links | edit)
- Ustekinumab (links | edit)
- Technetium (99mTc) fanolesomab (links | edit)
- Besilesomab (links | edit)
- Lemalesomab (links | edit)
- Technetium (99mTc) sulesomab (links | edit)
- Gavilimomab (links | edit)
- Afelimomab (links | edit)
- Faralimomab (links | edit)
- Aselizumab (links | edit)
- Atorolimumab (links | edit)
- Belimumab (links | edit)
- Bertilimumab (links | edit)
- Cedelizumab (links | edit)
- Ipilimumab (links | edit)
- Lerdelimumab (links | edit)
- Metelimumab (links | edit)
- Zanolimumab (links | edit)
- Zolimomab aritox (links | edit)
- Elsilimomab (links | edit)
- Inolimomab (links | edit)
- Odulimomab (links | edit)
- Vepalimomab (links | edit)
- Galiximab (links | edit)
- Golimumab (links | edit)
- Maslimomab (links | edit)
- Keliximab (links | edit)
- Lumiliximab (links | edit)
- Teneliximab (links | edit)
- Vapaliximab (links | edit)
- Tremelimumab (links | edit)
- Erlizumab (links | edit)
- Fontolizumab (links | edit)
- Ocrelizumab (links | edit)
- Pascolizumab (links | edit)
- Pexelizumab (links | edit)
- Reslizumab (links | edit)
- Rovelizumab (links | edit)
- Ruplizumab (links | edit)
- Siplizumab (links | edit)
- Talizumab (links | edit)
- Tocilizumab (links | edit)
- Toralizumab (links | edit)
- Visilizumab (links | edit)
- Mepolizumab (links | edit)
- Abatacept (links | edit)
- Epratuzumab (links | edit)
- Nerelimomab (links | edit)
- Tumor necrosis factor superfamily (links | edit)
- Priliximab (links | edit)
- Hidradenitis (links | edit)
- Hepatosplenic T-cell lymphoma (links | edit)
- Lymphotoxin beta receptor (links | edit)
- WHO Model List of Essential Medicines (links | edit)
- Morolimumab (links | edit)
- Canakinumab (links | edit)
- Ibalizumab (links | edit)
- Teplizumab (links | edit)
- Temsirolimus (links | edit)
- Otelixizumab (links | edit)
- Laquinimod (links | edit)
- Lebrikizumab (links | edit)
- Serum sickness (links | edit)
- Biosimilar (links | edit)
- List of largest selling pharmaceutical products (links | edit)
- Research in multiple sclerosis (links | edit)
- Tumor necrosis factor receptor 1 (links | edit)
- YWHAH (links | edit)
- Lymphotoxin alpha (links | edit)
- Lymphotoxin beta (links | edit)
- Adult-onset Still's disease (links | edit)
- Leronlimab (links | edit)
- Chronic recurrent multifocal osteomyelitis (links | edit)
- Tumor necrosis factor receptor 2 (links | edit)
- Rilonacept (links | edit)
- Ridaforolimus (links | edit)
- Outline of immunology (links | edit)
- Innerstate (links | edit)
- Dimethyl fumarate (links | edit)
- Aflibercept (links | edit)
- Zotarolimus (links | edit)
- Autoimmune inner ear disease (links | edit)
- Mizoribine (links | edit)
- Abetimus (links | edit)
- Teriflunomide (links | edit)
- Merck Headquarters Building (links | edit)
- Clenoliximab (links | edit)
- Telimomab aritox (links | edit)
- Anti-dsDNA antibodies (links | edit)
- Obinutuzumab (links | edit)
- Vedolizumab (links | edit)
- Coppertone sign (links | edit)
- Marc Feldmann (links | edit)
- Blau syndrome (links | edit)
- Psoriatic onychodystrophy (links | edit)
- Psoriatic erythroderma (links | edit)
- Siltuximab (links | edit)
- PAPA syndrome (links | edit)
- Pomalidomide (links | edit)
- Drug-induced aseptic meningitis (links | edit)
- Semapimod (links | edit)
- N-linked glycosylation (links | edit)
- The Merck Manuals (links | edit)
- Fresolimumab (links | edit)
- Umirolimus (links | edit)
- Clazakizumab (links | edit)
- Rontalizumab (links | edit)
- Briakinumab (links | edit)
- Pegsunercept (links | edit)
- Pirfenidone (links | edit)
- Benralizumab (links | edit)
- Tilomisole (links | edit)
- Mouth and genital ulcers with inflamed cartilage syndrome (links | edit)
- ATC code L04AB02 (redirect page) (links | edit)
- ATCvet code QL04AB02 (redirect page) (links | edit)
- Rochelle Lazarus (links | edit)
- Tofacitinib (links | edit)
- Temozolomide (links | edit)
- Merck & Co. (links | edit)
- Behçet's disease (links | edit)
- Enteropathic arthropathy (links | edit)
- Cubist Pharmaceuticals (links | edit)
- Brodalumab (links | edit)
- Carlumab (links | edit)
- Etrolizumab (links | edit)
- Gevokizumab (links | edit)
- Ixekizumab (links | edit)
- Mavrilimumab (links | edit)
- Mogamulizumab (links | edit)
- Oxelumab (links | edit)
- Ozoralizumab (links | edit)
- Samalizumab (links | edit)
- Secukinumab (links | edit)
- Sirukumab (links | edit)
- Tralokinumab (links | edit)
- Urelumab (links | edit)
- Sifalimumab (links | edit)
- Fezakinumab (links | edit)
- Tabalumab (links | edit)
- Sarilumab (links | edit)
- Namilumab (links | edit)
- Ublituximab (links | edit)
- Tregalizumab (links | edit)
- Vatelizumab (links | edit)
- Pateclizumab (links | edit)
- Foralumab (links | edit)
- Itolizumab (links | edit)
- Olokizumab (links | edit)
- Lloyd Mayer (links | edit)
- Anrukinzumab (links | edit)
- BMS-470539 (links | edit)
- Nivolumab (links | edit)
- Placulumab (links | edit)
- Baricitinib (links | edit)
- Quilizumab (links | edit)
- Apremilast (links | edit)
- Dupilumab (links | edit)
- Pidilizumab (links | edit)
- Tildrakizumab (links | edit)
- MTOR inhibitors (links | edit)
- Voclosporin (links | edit)
- Drug nomenclature (links | edit)
- Lampalizumab (links | edit)
- Lirilumab (links | edit)
- Ligelizumab (links | edit)
- Perakizumab (links | edit)
- Eldelumab (links | edit)
- Guselkumab (links | edit)
- Pembrolizumab (links | edit)
- Plant manufactured pharmaceuticals (links | edit)
- Ezetimibe/atorvastatin (links | edit)
- Anifrolumab (links | edit)
- Bimagrumab (links | edit)
- The Rheumatoid Arthritis Quality of Life Questionnaire (links | edit)
- Psoriatic Arthritis Quality of Life (links | edit)
- List of patient-reported quality of life surveys (links | edit)
- Autoimmune enteropathy (links | edit)
- Cereblon E3 ligase modulator (links | edit)
- Acceleron Pharma (links | edit)
- RVSV-ZEBOV vaccine (links | edit)
- Ponesimod (links | edit)
- H. K. Mulford Company (links | edit)
- Human anti-chimeric antibody (links | edit)
- Remsima (redirect page) (links | edit)
- Filgotinib (links | edit)
- Celltrion (links | edit)
- Abrilumab (links | edit)
- Lulizumab pegol (links | edit)
- Varlilumab (links | edit)
- Ulocuplumab (links | edit)
- Durvalumab (links | edit)
- Chronic relapsing inflammatory optic neuropathy (links | edit)
- Omarigliptin (links | edit)
- Ozanimod (links | edit)
- BIIB033 (links | edit)
- Viralytics (links | edit)
- Siponimod (links | edit)
- Vogt–Koyanagi–Harada disease (links | edit)
- Risankizumab (links | edit)
- Lenzilumab (links | edit)
- Inebilizumab (links | edit)
- Plozalizumab (links | edit)
- Tezepelumab (links | edit)
- Lanadelumab (links | edit)
- Vobarilizumab (links | edit)
- Brazikumab (links | edit)
- Crizanlizumab (links | edit)
- Tislelizumab (links | edit)
- Emapalumab (links | edit)
- Peficitinib (links | edit)
- WHO Model List of Essential Medicines for Children (links | edit)
- Cameron Prize for Therapeutics of the University of Edinburgh (links | edit)
- Upadacitinib (links | edit)
- Inflectra (redirect page) (links | edit)
- Cemiplimab (links | edit)
- Letolizumab (links | edit)
- Oleclumab (links | edit)
- Bleselumab (links | edit)
- Pamrevlumab (links | edit)
- Camidanlumab tesirine (links | edit)
- Andecaliximab (links | edit)
- Vulvar Crohn's disease (links | edit)
- Mirikizumab (links | edit)
- Ravulizumab (links | edit)
- Otilimab (links | edit)
- Lokivetmab (links | edit)
- Belumosudil (links | edit)
- Dostarlimab (links | edit)
- Relatlimab (links | edit)
- Spartalizumab (links | edit)
- Camrelizumab (links | edit)
- Bimekizumab (links | edit)
- Ianalumab (links | edit)
- Satralizumab (links | edit)
- Sutimlimab (links | edit)
- C6428H9912N1694O1987S46 (links | edit)
- Flixabi (redirect page) (links | edit)
- Zessly (redirect page) (links | edit)
- List of drugs: Z (links | edit)
- Ixifi (redirect page) (links | edit)
- Renflexis (redirect page) (links | edit)
- Avsola (redirect page) (links | edit)
- Infliximab-dyyb (redirect page) (links | edit)
- Infliximab-abda (redirect page) (links | edit)
- Infimab (redirect page) (links | edit)
- Darvadstrocel (links | edit)
- Alendronic acid/colecalciferol (links | edit)
- Solidarity trial (links | edit)
- Multisystem inflammatory syndrome in children (links | edit)
- Checkpoint inhibitor induced colitis (links | edit)
- RECOVERY Trial (links | edit)
- Imlifidase (links | edit)
- Lirentelimab (links | edit)
- Vericiguat (links | edit)
- Diroximel fumarate (links | edit)
- Antiarthritics (links | edit)
- Peripheral ulcerative keratitis (links | edit)
- Pegcetacoplan (links | edit)
- Zilucoplan (links | edit)
- Avacopan (links | edit)
- Efgartigimod alfa (links | edit)
- Nivolumab/relatlimab (links | edit)
- Spesolimab (links | edit)
- Deucravacitinib (links | edit)
- Iptacopan (links | edit)
- Remsima SC (redirect page) (links | edit)
- Retifanlimab (links | edit)
- Efgartigimod alfa/hyaluronidase (links | edit)
- Ritlecitinib (links | edit)
- Rozanolixizumab (links | edit)
- Avacincaptad pegol (links | edit)
- Frexalimab (links | edit)
- Etrasimod (links | edit)
- Crovalimab (links | edit)
- Zymfentra (redirect page) (links | edit)
- List of drugs: Z (links | edit)
- Danicopan (links | edit)
- Josef Smolen (links | edit)
- Drug antagonism (links | edit)
- Infliximab-qbtx (redirect page) (links | edit)
- Talk:Metabolic syndrome (links | edit)
- Talk:Infliximab (transclusion) (links | edit)
- Talk:Amgen (links | edit)
- Talk:Management of Crohn's disease (links | edit)
- Talk:Biological therapy for inflammatory bowel disease (links | edit)
- Talk:Natalizumab/Archive 1 (links | edit)
- Talk:Management of ulcerative colitis (links | edit)
- Talk:Natalizumab/Archive 2 (links | edit)
- Talk:Ulcerative colitis/Archive 2 (links | edit)
- Talk:List of drugs by year of discovery (links | edit)
- User:Jfdwolff/Braglist (links | edit)
- User:Stretchcat (links | edit)
- User:SelectionBot/0.7/M-3 (links | edit)
- User:Maralia/medwatchlist (links | edit)
- User:Jfdwolff (links | edit)
- User:MastCell/FDA links (links | edit)
- User:A E Francis/Cases (links | edit)
- User:Beetstra/listing23 (links | edit)
- User:Showstopper224 (links | edit)
- User:FrescoBot/WildBotlist5 (links | edit)
- User:Simoncaulton/Anti dsDNA (links | edit)
- User:HlynurT/Discovery and development of thalidomide and its analogs (links | edit)
- User:Lybbar12/Drug discovery and development of mTOR inhibitors (links | edit)
- User:Lybbar12/Discovery and development of mTOR inhibitors (links | edit)
- User:Meodipt/backup3 (links | edit)
- User:Meodipt/backup2 (links | edit)
- User:Meodipt/backup4 (links | edit)
- User:Wouterstomp/Suggestions (links | edit)
- User:Stephensrezrah/Books/TuBerCulosis (links | edit)
- User:Pthakker1/Books/Biotherapeutics of Interest (links | edit)
- User:Fuse809/sandbox6 (links | edit)
- User:Dna 621/sandbox (links | edit)
- User:Sarwhut/Books/My IBD (links | edit)
- User:West.andrew.g/2014 Top Medical Articles (links | edit)
- User:West.andrew.g/Popular medical pages (links | edit)
- User:Rocko1569/sandbox (links | edit)
- User:M dee gee/sandbox (links | edit)
- User:Waltpren/Books/Immunology G -Z (links | edit)
- User:Waltpren/Books/ONCOLOGY IMMUNOLOGY (links | edit)
- User:Waltpren/Books/ONCOLOGY IMMUNOLOGY G - H (links | edit)
- User:Waltpren/Books/ONCOLOGY IMMUNOLOGY1 H - Z (links | edit)
- User:Ericwen229/Books/Crohn's Me (links | edit)
- User:Vaibik/Books/Anklyosing Spondylitis (links | edit)
- User:Anusha honnur/sandbox (links | edit)
- User:PriceDL/List of all WikiProject Medicine articles (links | edit)
- User:Brainist/MeSH articles (links | edit)
- User:CFCF/sandbox/46 (links | edit)
- User:Doc James/DDD (links | edit)
- User:JakubecM/sandbox (links | edit)
- User:Mike Peel/Cochrane used (links | edit)
- User:Amélie C. Martin/sandbox (links | edit)
- User:Mattsnod/sandbox (links | edit)
- User:Teeconway11/sandbox (links | edit)
- User:Vsiemion/sandbox (links | edit)
- User:Xanthochromia/sandbox (links | edit)
- User:ETYL27/Exercise and cerebral palsy (links | edit)
- User:PearsonSingbeil (links | edit)
- User:Mr. Ibrahem/Pyoderma gangrenosum (links | edit)
- User:Qwerfjkl/preservedCategories/Category:CS1: long volume value (links | edit)
- User:Y-S.Ko/Wikipedia course/Medical/Allergy (links | edit)
- User:JZindler/sandbox-Amgen-updates (links | edit)
- User:M-Khemist/sandbox (links | edit)
- User:Nt4uic/Immune reconstitution inflammatory syndrome (links | edit)
- User:Y-S.Ko/Wikipedia course/Pharmacology/L-V (links | edit)
- User:Petermgrund/Autoimmune diseases (links | edit)
- User:Noxoug1/rozanolixizumab (links | edit)
- User:RudolfoMD/sandbox2 (links | edit)
- User talk:Crohnie/Archive 1 (links | edit)
- User talk:Statesman 88 (links | edit)
- User talk:Cjewell/Archive May 2007 (links | edit)
- User talk:Boghog/Archive 5 (links | edit)
- User talk:202.153.41.146 (links | edit)
- User talk:62.254.7.163 (links | edit)
- User talk:148.76.124.130 (links | edit)
- User talk:73.138.21.82 (links | edit)
- Wikipedia:WikiProject Medicine/Gastroenterology task force (links | edit)
- Wikipedia:WikiProject Chemicals/AlphabeticalList (links | edit)
- Wikipedia:Recent additions 80 (links | edit)
- Wikipedia:Help desk/Archive 61 (links | edit)
- Wikipedia:0.7/0.7index/Medicine and health (links | edit)
- Wikipedia:0.7/0.7alpha/I1 (links | edit)
- Wikipedia:Recent additions/2006/August (links | edit)
- Wikipedia:WikiProject Pharmacology/Log/2009-11-15 (links | edit)
- Wikipedia:WikiProject Pharmacology/Log/2009-12-14 (links | edit)
- Wikipedia:WikiProject Pharmacology/Log/2009-12-18 (links | edit)
- Wikipedia:WikiProject Pharmacology/Log/2010-01-13 (links | edit)
- Wikipedia:WikiProject Pharmacology/Log/2010-03-11 (links | edit)
- Wikipedia:WikiProject Pharmacology/Log/2010-04-16 (links | edit)
- Wikipedia:0.8/Index/I1 (links | edit)
- Wikipedia:WikiProject Pharmacology/Log/2011-01-12 (links | edit)
- Wikipedia:WikiProject Pharmacology/Log/2011-05-09 (links | edit)
- Wikipedia:WikiProject Pharmacology/Log/2011-05-16 (links | edit)
- Wikipedia:WikiProject Pharmacology/Log/2011-08-14 (links | edit)
- Wikipedia:WikiProject Pharmacology/Log/2011-08-20 (links | edit)
- Wikipedia:WikiProject Pharmacology/Log/2011-10-30 (links | edit)
- Wikipedia:WikiProject Pharmacology/Log/2011-10-31 (links | edit)
- Wikipedia:WikiProject Medicine/Lists of pages/Articles (links | edit)
- Wikipedia:WikiProject Medicine/Lists of pages/Top-, High-importance medicine articles (links | edit)
- Wikipedia:WikiProject Pharmacology/Lists of pages/Pharmacology articles (links | edit)